SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001654954-21-001543
Filing Date
2021-02-12
Accepted
2021-02-11 20:08:08
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B4 gtbp_424b4.htm 424B4 2064823
2 IMAGE gtbp_s1000.jpg GRAPHIC 2685
3 IMAGE gtbp_s10001.jpg GRAPHIC 29192
4 IMAGE gtbp_s10002.jpg GRAPHIC 20611
5 IMAGE gtbp_s10003.jpg GRAPHIC 23227
6 IMAGE gtbp_s1001.jpg GRAPHIC 29310
7 IMAGE gtbp_s1002.jpg GRAPHIC 6309
8 IMAGE gtbp_s1013.jpg GRAPHIC 5497
  Complete submission text file 0001654954-21-001543.txt   2227998
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-251311 | Film No.: 21621945
SIC: 2834 Pharmaceutical Preparations